Patents Assigned to Medipure Pharmaceuticals Inc.
  • Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product
    Patent number: 11147805
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: October 19, 2021
    Assignee: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi Tiwari-Pandey, Rakshit Devappa Kodekalra, Nihar R. Pandey
  • CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT
    Publication number: 20200253947
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Application
    Filed: February 7, 2019
    Publication date: August 13, 2020
    Applicant: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi Tiwari-Pandey, Rakshit Devappa Kodekalra, Nihar R. Pandey
  • CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT
    Publication number: 20200253948
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Application
    Filed: October 31, 2019
    Publication date: August 13, 2020
    Applicant: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi TIWARI-PANDEY, Rakshit Devappa KODEKALRA, Nihar R. PANDEY